ANI Pharmaceuticals Inc (ANIP) — Free Cash Flow Yield
Biotech & Pharma
| Metric | Value |
|---|---|
| FCF Yield | 10.4% |
| Biotech & Pharma Sector Avg FCF Yield | 14.3% |
| Annual Free Cash Flow | $173M |
| Market Cap | $1.7B |
| P/E Ratio | 22.4x |
ANI Pharmaceuticals Inc's FCF yield of 10.4% is below the Biotech & Pharma sector average (14.3%).
Frequently Asked Questions
What is ANI Pharmaceuticals Inc's (ANIP) free cash flow yield?
ANI Pharmaceuticals Inc's (ANIP) free cash flow yield is 10.4%. That is below the Biotech & Pharma sector average (14.3%).
Is ANIP's free cash flow yield good?
At 10.4%, ANIP's free cash flow yield is considered excellent — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does ANI Pharmaceuticals Inc generate?
ANI Pharmaceuticals Inc generated $173M in free cash flow, against a market cap of $1.7B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →